Ophthalmology Times Staff Reports

The National Keratoconus Foundation has named NASCAR driver Joey Gase as Ambassador.

The University of California San Francisco this week debuted the UCSF Wayne and Gladys Valley Center for Vision, bringing its vision care and research facilities under one roof.

The American Medical Association is expressing its support for provisions in proposed Continuing Resolution legislation in Congress that could offer relief to financially strapped physician practices.

Intravitreal injection treats rare autoimmune disease of the central nervous system

Aflibercept (Eylea, Regeneron) has gained FDA approval for treatment of macular edema following CRVO and recommendation for approval by the CHMP for treatment of neovascular AMD.

A phase IIa proof of concept study of a novel rho-kinase (ROCK) inhibitor (AMA0076, Amakem NV) is now underway in patients with glaucoma and ocular hypertension.

QLT Inc. announces that it has completed sale of verteporfin for injection (Visudyne) to Valeant Pharmaceuticals International Inc.

A scientific research grant to cover studies related to dry eye and ocular surface disease will be awarded by CLAO ERF in association with the SSF.

AcuFocus Inc. has received approval from Health Canada to market and sell the Kamra inlay, an innovative corneal inlay to treat presbyopia, within Canada.

The iDesign aberrometer (Abbott) provides an advanced, high-definition measurement device for wavefront-guided LASIK procedures.

The AcrySof IQ ReSTOR +2.5-D IOL offers sharp distance vision with an additional range of vision beyond a standard monofocal lens.

The enVista Toric IOL was launched by Bausch + Lomb at the 2012 Congress of European Society of Cataract and Refractive Surgeons.

The American Academy of Ophthalmology (AAO) recognized in a statement the passing of Yasuo Tano, MD, president of the Asia-Pacific Academy of Ophthalmology and immediate past president of the Japanese Ophthalmological Society.

Paul Bryar, MD, an ophthalmologist from Chicago, is running as a democratic candidate in the Illinois special primary election that will take place March 3, according to a release issued by the American Society of Cataract and Refractive Surgery.

Bausch &. Lomb has launched a new advertising campaign in six Florida markets aimed to educate baby boomers and seniors about its proprietary FDA-approved accommodating IOL (Crystalens), the company announced in a prepared statement.

The Standard Occupational Classification listing encompasses all three levels of JCAHPO certification: certified ophthalmic assistant, certified ophthalmic technician, and certified ophthalmic medical technologist, the organization said.

Pfizer will disclose publicly its compensation of U.S. health-care professionals for consulting, speaking engagements, and clinical trials by early next year on the company’s Web site, according to a prepared statement from the company.

Dyax Corp. and Fovea Pharmaceuticals announced in a joint statement that they have entered into an exclusive license agreement for the development and commercialization of an ocular formulation of DX-88 for the treatment of retinal diseases.